U.S. v. Arthrex | Association for Accessible Medicines
In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.
AAM Amicus Brief

U.S. v. Arthrex

On December 2, 2020 AAM filed a brief in the Supreme Court in U.S. v. Arthrex, the latest constitutional challenge to IPR – urging the Court to uphold the system. Among other things, the brief explains how IPR is a necessary tool to combat pharmaceutical patent abuse.

View Brief

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.